Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 3, 2019
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Accelerate Diagnostics, Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 1
| |||||||
Accelerate Diagnostics, Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Accelerate Diagnostics, Inc
|
0
|
—
|
—
|
—
|
0
|
Mar 7
| |||||||
Accelerate Diagnostics, Inc
| -223.22K |
$22.40 | -$5,000,016.00 | -22.65% | 762.38K |
Aug 17
|
Scheduled
| ||||||
Accelerate Diagnostics, Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 23
| |||||||
Accelerate Diagnostics, Inc
| -29.76K |
$10.50 | -$6,860,678.00 | -2.93% | 985.6K |
Jan 9
| |||||||
Accelerate Diagnostics, Inc
|
0
|
—
|
—
|
—
|
0
|
Mar 18
| |||||||
Accelerate Diagnostics, Inc
| 500 |
$20.48 | $10,240.00 |
∞
| 500 |
Mar 17
| |||||||
Accelerate Diagnostics, Inc
|
0
|
—
|
—
|
—
|
0
|
May 29
| |||||||
Accelerate Diagnostics, Inc
| 4K |
$16.80 | $67,200.00 | +0.25% | 1.58M |
May 2
| |||||||
Accelerate Diagnostics, Inc
| -12.42M |
$1.49 | $20,067,680.00 | -88.74% | 1.58M |
Mar 6
| |||||||
Accelr8 Technology Corp
| 14M |
$1.03 | $14,420,000.00 |
∞
| 14M |
Jun 26
| |||||||
Accelr8 Technology Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ventana Medical Systems Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 19
| |||||||
Ventana Medical Systems Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
May 23
| ||||||
Ventana Medical Systems Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ventana Medical Systems Inc
|
0
|
—
|
—
|
—
|
0
|
Apr 5
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||